NCT03050086: An overdue trial by BioPharmX, Inc.
This trial is overdue. It was due to report 5 years, 9 months ago.
Think we've made a mistake? Before contacting us, review the criteria in our paper. In particular, bear in mind the following:
- We can only rely on the structured data that sponsors put into the registry: they may enter incorrect or incomplete data.
- Reporting in a journal is not enough. The FDAAA rules state that the trial must be reported on ClinicalTrials.gov.
- Terminated trials are required to report results. Only withdrawn trials (which never recruited a single patient) are not.
Full data
| Full entry on ClinicalTrials.gov | NCT03050086 |
|---|---|
| Title | An Open Label Phase 2 Feasibility Study to Assess the Safety and Efficacy of BPX-04 Minocycline Topical Gel in Treatment of Moderate to Severe Papulopustular Rosacea (BPX-01-C05) |
| Results Status | Overdue |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 29, 2017 |
| Completion date | June 19, 2018 |
| Required reporting date | June 19, 2019, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 4, 2025 |
| Days late | 2116 |